Inactive Instrument
Checkmate Pharmaceuticals, Inc. Share Price
Stocks
CMPI
US1628181083
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 11/12/2018 | |
Robert Landry
DFI | Director of Finance/CFO | 62 | 30/05/2022 |
Chris French
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 30/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/05/22 | Issuer sale | Director | 36,778 | 0.1700% | ||
| 31/05/22 | Issuer sale | Chief Financial Officer | 278,480 | 1.2874% | ||
| 31/05/22 | Issuer sale | Chief Executive Officer | 279,437 | 1.2919% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.38% | - | - | 231M | |
| -6.60% | -8.56% | +42.79% | +64.16% | 65B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 51.19B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 51.2B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 43.93B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 41.96B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 38.14B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 33.24B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.2B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.03B | |
| Average | -1.66% | -1.67% | +43.33% | +85.71% | 41.32B | |
| Weighted average by Cap. | -2.30% | -1.21% | +43.56% | +88.58% |
Employees
31
